Steven Skolsky joins Quintiles


To head the clinical development leadership team

Quintiles, a US-headquartered biopharmaceutical firm, has appointed Steven Skolsky as global head of its Clinical & Data Operations (CDO) unit, the core of the company’s Clinical Development division that monitors the clinical conduct at research sites and collects and manages data from patients in clinical trials conducted around the world.

A 30-year veteran of the biopharmaceutical industry, Skolsky will lead the CDO unit, which unites Clinical Data Management and Clinical Operations under one umbrella, and employees 5,000 people.

Skolsky previously served as vice chairman of the board and is a current board director for Basilea Pharmaceutica, a Basel, Switzerland-based pharmaceutical company. He is also on the board of directors of Adherex Technologies, a clinical stage oncology company based in Raleigh, NC. Most recently, he was principal at Expis Partners, a strategic life science consultancy.

In a separate announcement, Quintiles has opened its new European headquarters in Reading, UK, bringing together more than 500 staff who were previously in three separate offices.

Quintiles employs more than 2,000 people in the UK and more than 9,000 across Europe, Middle East and Africa.